SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001267602-23-000119
Filing Date
2023-10-26
Accepted
2023-10-26 07:39:33
Documents
14
Period of Report
2023-10-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alim-20231026x8k.htm   iXBRL 8-K 65661
2 EX-99.1 alim-20231026xex99_1.htm EX-99.1 239476
3 GRAPHIC alim-20231026xex99_1g001.jpg GRAPHIC 55720
  Complete submission text file 0001267602-23-000119.txt   523809

Data Files

Seq Description Document Type Size
4 EX-101.SCH alim-20231026.xsd EX-101.SCH 2169
5 EX-101.LAB alim-20231026_lab.xml EX-101.LAB 18363
6 EX-101.PRE alim-20231026_pre.xml EX-101.PRE 11527
8 EXTRACTED XBRL INSTANCE DOCUMENT alim-20231026x8k_htm.xml XML 4861
Mailing Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005
Business Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34703 | Film No.: 231347521
SIC: 2834 Pharmaceutical Preparations